Amgen Inc at Cowen HealthCare Conference Transcript

Mar 02, 2020 / 04:20PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay. Well, good morning, everybody. And once again, thank you so much for joining us for Cowen's 40th Annual Healthcare Conference here at Boston. My name is Yaron Werber. I'm one of the biotech analysts here at Cowen, and it's a great pleasure to moderate the fireside chat with Amgen. Note that we're not going to have a breakout, we're going to have a fireside chat instead.

So it's terrific to welcome Peter Griffith, who is Executive Vice President and CFO, on the right; and then to his left is Murdo Gordon, who's EVP of Global Commercial Operations; and to his left, Arvind Sood, Vice President of Investor Relations. Gentlemen, thank you so much for joining us. We appreciate it.

So as we discussed ahead of time, I'm going to direct all clinical questions to Peter and then all science questions are going to go to Murdo.

Peter H. Griffith - Amgen Inc. - Executive VP & CFO

There we go. You can give them all to Arvind. Arvind is trying

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot